|
|
|
An aspirin a day could keep skin cancer away, according to a new report in the journal Cancer.
Researchers in Denmark and the U.S. found that people taking common painkillers like aspirin and ibuprofen were less likely to develop skin cancer - including squamous cell carcinoma and malignant melanoma - especially when they took the drugs for at least seven years or used them at least twice a week. It’s not the first study to show a potential anticancer effect of aspirin and other similar painkillers - a class of medications known and nonsteroidal anti-inflammatory drugs, or NSAIDs. Previous studies have found that aspirin users enjoyed a lower risk of colon cancer; a trial published earlier this year concluded that people who take a daily aspirin have as much as a 46% lower risk of colon, lung and prostate cancers, compared with non-users.
To localize:
Check out story ideas, interesting ways to use Web tools and any way journalists are reaching out to readers.
